Cart
sales@molnova.com
(R)-CR8
CAS No. 294646-77-8
(R)-CR8 ( CR8 ,(R)-Isomer )
Catalog No. M22098 CAS No. 294646-77-8
(R)-CR8 is a potent and selective CDK inhibitor.A delayed systemic post-LFP administration at 3 hours of CR8--a potent second-generation cyclin-dependent kinase (CDK) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 405 | In Stock |
|
| 10MG | 597 | In Stock |
|
| 25MG | 888 | In Stock |
|
| 50MG | 1251 | In Stock |
|
| 100MG | 1692 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(R)-CR8
-
NoteResearch use only, not for human use.
-
Brief Description(R)-CR8 is a potent and selective CDK inhibitor.A delayed systemic post-LFP administration at 3 hours of CR8--a potent second-generation cyclin-dependent kinase (CDK) inhibitor.
-
Description(R)-CR8 is a potent and selective CDK inhibitor.A delayed systemic post-LFP administration at 3 hours of CR8--a potent second-generation cyclin-dependent kinase (CDK) inhibitor--reduced CCA;?cortical, hippocampal, and thalamic neuronal loss;?and cortical microglial and astrocyte activation.?Furthermore, CR8 treatment attenuated sensorimotor and cognitive deficits, alleviated depressive-like symptoms, and decreased lesion volume.
-
SynonymsCR8 ,(R)-Isomer
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number294646-77-8
-
Formula Weight431.53
-
Molecular FormulaC24H29N7O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC[C@H](CO)Nc1nc(NCc2ccc(cc2)-c2ccccn2)c2ncn(C(C)C)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kabadi SV, et al. CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2014 Mar;34(3):502-13.
molnova catalog
related products
-
SU-9516
SU9516 is a selectively potent ATP-competitive inhibitor of CDKs.
-
Butyrolactone I
Butyrolactone I is an ATP-competitive inhibitor of CDK and cdc2 kinase family.
-
KB-0742 dihydrochlor...
KB-0742 dihydrochloride is a potent, selective and orally inhibitor of ?CDK9.
